Gupta N - Search Results

1

BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor-resistant BRCA-mutant ovarian cancer.

Gupta N, Huang TT, Nair JR, An D, Zurcher G, Lampert EJ, McCoy A, Cimino-Mathews A, Swisher EM, Radke MR, Lockwood CM, Reichel JB, Chiang CY, Wilson KM, Cheng KC, Nousome D, Lee JM. Gupta N, et al. Sci Transl Med. 2023 Jun 21;15(701):eadd7872. doi: 10.1126/scitranslmed.add7872. Epub 2023 Jun 21. Sci Transl Med. 2023. PMID: 37343085 Free PMC article. Clinical Trial.

2

Cell cycle checkpoints and beyond: Exploiting the ATR/CHK1/WEE1 pathway for the treatment of PARP inhibitor-resistant cancer.

Gupta N, Huang TT, Horibata S, Lee JM. Gupta N, et al. Pharmacol Res. 2022 Apr;178:106162. doi: 10.1016/j.phrs.2022.106162. Epub 2022 Mar 5. Pharmacol Res. 2022. PMID: 35259479 Free PMC article. Review.

3

Distinct roles of treatment schemes and BRCA2 on the restoration of homologous recombination DNA repair and PARP inhibitor resistance in ovarian cancer.

Huang TT, Burkett SS, Tandon M, Yamamoto TM, Gupta N, Bitler BG, Lee JM, Nair JR. Huang TT, et al. Among authors: gupta n. Oncogene. 2022 Nov;41(46):5020-5031. doi: 10.1038/s41388-022-02491-8. Epub 2022 Oct 12. Oncogene. 2022. PMID: 36224341 Free PMC article.

4

Carving a niche for immunotherapy in ovarian cancer.

Gupta N, Lampert E, Lee JM. Gupta N, et al. Oncotarget. 2021 Jan 5;12(1):4-7. doi: 10.18632/oncotarget.27864. eCollection 2021 Jan 5. Oncotarget. 2021. PMID: 33456707 Free PMC article. No abstract available.

5

Macular corneal dystrophy with iridofundal coloboma in the same patient: a unique combination.

Gupta N, Panigrahi A, Gupta N, Sen S. Gupta N, et al. BMJ Case Rep. 2024 May 8;17(5):e258786. doi: 10.1136/bcr-2023-258786. BMJ Case Rep. 2024. PMID: 38719268

6

Establishing a Health Technology Assessment Evidence Ecosystem in India's Pradhan Mantri Jan Arogya Yojana.

Prinja S, Chugh Y, Gupta N, Aggarwal V. Prinja S, et al. Among authors: gupta n. Health Syst Reform. 2023 Dec 31;9(3):2327097. doi: 10.1080/23288604.2024.2327097. Epub 2024 May 7. Health Syst Reform. 2023. PMID: 38715207

7

Frailty in intracranial meningioma resection: the risk analysis index demonstrates strong discrimination for predicting non-home discharge and in-hospital mortality.

Covell MM, Roy JM, Gupta N, Raihane AS, Rumalla KC, Lima Fonseca Rodrigues AC, Courville E, Bowers CA. Covell MM, et al. Among authors: gupta n. J Neurooncol. 2024 May 7. doi: 10.1007/s11060-024-04703-5. Online ahead of print. J Neurooncol. 2024. PMID: 38713325

8

Tall-columnar glandular cells in SurePath™ liquid-based cytology Pap sample: Learning from mimics/pitfalls.

Gupta N, Jain V, Srinivasan R, Singh T. Gupta N, et al. Cytopathology. 2024 May 7. doi: 10.1111/cyt.13385. Online ahead of print. Cytopathology. 2024. PMID: 38712698

9

Therapeutic Activity of Resolvin D1 (RvD1) in Murine MASH.

Navarro-Corcuera A, Zhu Y, Ma F, Gupta N, Asplund H, Yuan F, Friedman S, Sansbury BE, Huang X, Cai B. Navarro-Corcuera A, et al. Among authors: gupta n. bioRxiv [Preprint]. 2024 Apr 26:2024.04.22.590633. doi: 10.1101/2024.04.22.590633. bioRxiv. 2024. PMID: 38712196 Free PMC article. Preprint.

10

Contemporaneous Illustration of Megakaryopoiesis.

Gupta N, Dadu T, Mittal A, Handoo A. Gupta N, et al. Indian J Hematol Blood Transfus. 2024 Apr;40(2):364-365. doi: 10.1007/s12288-023-01674-x. Epub 2023 Jul 10. Indian J Hematol Blood Transfus. 2024. PMID: 38708159 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8,192 results

Search Page